Paxlovid for hospitalized COVID-19 patients with chronic kidney disease

COVID-19 causes significant mortality during the recent pandemic. Data regarding the effectiveness of Paxlovid on COVID-19 patients with chronic kidney disease (CKD, eGFR <90 ml/min) are limited. A retrospective cohort study was performed on the clinical data of the hospitalized adult patients wi...

Full description

Saved in:

Bibliographic Details
Published in:	Antiviral research Vol. 216; p. 105659
Main Authors:	Cai, Hong, Yan, Jiayi, Liu, Shang, Li, Ping, Ding, Li, Zhan, Yaping, Lu, Jiayue, Li, Zhenyuan, Sun, Yiwen, Zhu, Mingli, Gao, Yuan, Gong, Xingrong, Ban, Haiqun, Gu, Leyi, Zhou, Weibin, Wang, Jieying, Mou, Shan
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01-08-2023 Published by Elsevier B.V
Subjects:	Adult All-cause death Chronic kidney disease COVID-19 COVID-19 - complications Humans Paxlovid Renal Insufficiency, Chronic - complications Retrospective Studies Risk Factors Viral elimination COVID-19 Viral elimination Paxlovid Chronic kidney disease All-cause death
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!